Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 19.81B P/E ratio 2024 *
26.4x
P/E ratio 2025 * 18.5x
Enterprise value 30B EV / Sales 2024 *
1.97x
EV / Sales 2025 * 1.88x
Free-Float
74.34%
Yield 2024 *
3.04%
Yield 2025 * 3.17%
More valuation ratios * Estimated data
Dynamic Chart
1 day+3.44%
1 week+1.73%
Current month+2.32%
1 month+12.07%
3 months+16.96%
6 months-8.46%
Current year+0.41%
More quotes
1 week
37.13
Extreme 37.13
39.01
1 month
33.85
Extreme 33.85
39.01
Current year
32.48
Extreme 32.48
44.01
1 year
31.01
Extreme 31.01
44.01
3 years
31.01
Extreme 31.01
89.70
5 years
31.01
Extreme 31.01
95.19
10 years
31.01
Extreme 31.01
95.19
More quotes
Director TitleAgeSince
Chief Executive Officer 61 15-09-30
Director of Finance/CFO 54 23-10-17
Chief Tech/Sci/R&D Officer - 18-12-31
Manager TitleAgeSince
Chief Executive Officer 61 15-09-30
Director/Board Member 73 17-02-05
Director/Board Member 60 17-07-17
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+3.44%+1.73%-0.44%-53.06%19.81B
-1.14%+0.30%+12.11%-12.28%197B
-1.80%+1.36%+11.46%-33.60%115B
-1.31%-3.20%-14.52%-9.53%67.42B
-2.94%-0.57%+36.66%+88.78%46.3B
-0.47%-7.09%+15.06%+6.42%46.57B
-0.08%-3.12%+14.03%-11.98%29.42B
-1.10%-0.82%-31.18%-49.08%27.67B
-0.13%-1.82%+20.74%+4.78%27.34B
-0.33%+0.56%+6.89%+9.75%23.57B
Average -0.59%-1.54%+7.08%-5.98% 59.95B
Weighted average by Cap. -1.09%-0.92%+8.99%-8.18%
See all sector performances
2024 *2025 *
Net sales 15.23B 15.75B
Net income 368M 878M
Net Debt 10.19B 9.78B
More financial data * Estimated data
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Employees
60,000
Related indices
More about the company
Date Price Change Volume
24-09-05 38.82 $ +3.44% 6,375,743
24-09-04 37.53 $ -0.85% 2,640,008
24-09-03 37.85 $ -0.24% 3,255,436
24-08-30 37.94 $ -0.58% 4,248,884
24-08-29 38.16 $ +0.90% 2,353,459

Delayed Quote Nyse, September 05, 2024 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
38.82USD
Average target price
42.09USD
Spread / Average Target
+8.43%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW